Document is current
Any future updates will be listed below
-
Authors
Chatziantoniou, Cyrano
van Ewijk, Roelof
Adams, Madeleine
Bertolini, Patrizia
Bisogno, Gianni
Bouhamama, Amine
Caro-Dominguez, Pablo
Charon, Valérie
Coma, Ana
Dandis, Rana
Devalck, Christine
De Donno, Giulia
Ferrari, Andrea
Fiocco, Marta
Gallego, Soledad
Giraudo, Chiara
Glosli, Heidi
ter Horst, Simone A. J.
Jenney, Meriel
Klein, Willemijn M.
Leemans, Alexander
Leseur, Julie
Mandeville, Henry C.
McHugh, Kieran
Merks, Johannes H. M.
Minard-Colin, Veronique
Moalla, Salma
Morosi, Carlo
Orbach, Daniel
Ording Müller, Lil-Sofie
Pace, Erika
Di Paolo, Pier Luigi
Perruccio, Katia
Quaglietta, Lucia
Renard, Marleen
van Rijn, Rick R.
Ruggiero, Antonio
Sirvent, Sara I.
Schoot, Reineke A.
De Luca, Alberto
-
Funding
Funding for this research was provided by:
Stichting Kinderen Kankervrij (357, 357)
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
Royal Marsden Cancer Charity
- License Information
-
More Information
Article History
Received: 10 October 2024
Revised: 24 April 2025
Accepted: 30 April 2025
First Online: 10 June 2025
Declarations
:
: We declare no conflict of interest or industry support related to this project. The authors who obtained the data do not work at and do not get any support from any company in the medical industry. Personal disclosures: Gianni Bisogno discloses participation on the advisory board of Bayer and GlaxoSmithKline. Willemijn Klein discloses leadership/fiduciary role as chair of the Dutch pediatric radiology society. Henry Mandeville discloses participation on the advisory board of Merck. Daniel Orbach discloses consultant work for the French Larotrectinib transparency committee, independent translational research supported by Bayer, participation on the advisory board of Lilly and consulting activities for Lilly, Bayer, Sanofi, Hoffman La Roche, Novartis and Eusapharm. Lil-Sofie Ording Müller discloses leadership/fiduciary role as chair of the European Society for Paediatric Radiology (ESPR) abdominal task force group. Pablo Caro discloses a role as chair of the ESPR cardio-thoracic taskforce group, and president of the ESPR 2024 congress.
